CD-Screen and CD-Screen-IEC columns may support method development across parent cyclodextrins, modified derivatives, formulation samples and ionic derivatives. Suitability must be demonstrated for the target analytical objective.
Parent cyclodextrin analysis
Alpha-, beta- and gamma-cyclodextrins can show limited retention on some conventional reversed-phase systems. CD-Screen methods may be investigated when more cyclodextrin-focused selectivity is required, with detector and sample compatibility established during development.
Residual parent cyclodextrins
Modified cyclodextrin materials may contain residual underivatized starting material. An analytical method may therefore need to distinguish the parent cyclodextrin from the wider derivative distribution and sample-matrix components.
Degradation-related components
Stability or forced-degradation work can generate altered cyclodextrin-related components. A CD-Screen-based method may be explored as one part of a specificity strategy, with validation appropriate to the intended use.
Statistically substituted cyclodextrins
Statistically substituted derivatives contain molecular populations that differ in substitution number and position. Chromatography can therefore produce a distribution profile rather than one discrete analyte peak. Repeatability and meaningful system-suitability criteria become especially important.
Pharmaceutical formulation samples
Cyclodextrins may be present alongside active ingredients and other excipients. Matrix effects, detector response, extraction and sample preparation should be evaluated before applying a method to formulation analysis.
SBECD and ionic derivatives
CD-Screen-IEC is the dedicated option for ionic cyclodextrin derivatives. For SBECD, potential analytical goals can include component distribution, degree of substitution and selected impurities such as BCD, HBSA and DBSA where a validated method demonstrates appropriate separation.
Method-development checklist
- Define the analyte, derivative type and sample matrix.
- Confirm detector compatibility and sensitivity needs.
- Assess mobile-phase composition and ionic conditions where relevant.
- Consider sample solvent and precipitation risk.
- Establish system suitability and robustness for the intended use.